DCFPyL PET/CT
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)
Enrolling by invitation
- Prostate Cancer
- 18F-DCFPyL PET/CT
-
Montreal, Quebec, CanadaJewish General Hospital
May 3, 2022
Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,
Enrolling by invitation
- Prostate Neoplasms
- +4 more
- 18F-DCFPyL
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Prostate Cancer Diagnosis Trial in Los Angeles (diagnostic test, other, drug)
Not yet recruiting
- Prostate Cancer Diagnosis
- PSMA PET scan
- +2 more
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 20, 2023
Prostate Carcinoma Trial in Duarte (procedure, other, device)
Recruiting
- Prostate Carcinoma
- Computed Tomography
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Active, not recruiting
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandSKCCC
Apr 5, 2022
Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)
Active, not recruiting
- Prostatic Neoplasms
- 18F- DCFPyL PET/CT
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,
No longer available
- Prostate Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jan 6, 2022
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Completed
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)
Withdrawn
- Prostate Cancer
- 18F-DCFPyL Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Prostate Cancer, Prostate Cancer Metastatic, Prostatic Tumor Trial in Vancouver (18F-DCFPyL PET/CT scan, Placebo drink, MSG
Completed
- Prostate Cancer
- +2 more
- 18F-DCFPyL PET/CT scan
- +2 more
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Prostate Cancer Trial in Québec (Enzalutamide capsule)
Recruiting
- Prostate Cancer
- Enzalutamide capsule
-
Québec, CanadaCHU de Québec-Université Laval
Mar 29, 2022
Metastatic Prostate Cancer Trial in New York ([F-18] DCFPyL, PET/CT imaging)
Active, not recruiting
- Metastatic Prostate Cancer
- [F-18] DCFPyL
- PET/CT imaging
-
New York, New YorkColumbia University Irving Medical Center
May 6, 2022
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
Recruiting
- Prostatic Neoplasms
- Prostate Cancer
- PSMA PET/CT scan
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 15, 2021
Prostate Cancer Trial (Pylarify Piflufolastat Flourine-18 (18F-DCFPyL))
Not yet recruiting
- Prostate Cancer
- Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
- (no location specified)
Jan 26, 2023
Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)
Completed
- Prostate Cancer
- 18F-DCFPyL PET/CT scan
-
Hamilton, Ontario, Canada
- +3 more
Mar 24, 2022
Prostate Cancer Trial in Baltimore (SPECT CT, 18F-DCFPyL PET/CT, 18F-NaF PET/CT)
Recruiting
- Prostate Cancer
- SPECT CT
- +3 more
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Prostate Cancer Trial in Los Angeles (18F-DCFPyL)
Recruiting
- Prostate Cancer
-
Los Angeles, CaliforniaVA Greater Los Angeles Healthcare System
Apr 6, 2021
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (18F-DCFPyL)
Recruiting
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- 18F-DCFPyL
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Mar 31, 2021
Prostate Cancer Trial in Canada, United States (18F-DCFPyL Injection, PET/CT imaging)
Completed
- Prostate Cancer
- 18F-DCFPyL Injection
- PET/CT imaging
-
San Francisco, California
- +9 more
Aug 6, 2021
Prostate Cancer Recurrent Trial in Saint-Beauzire (DCFPyL)
Unknown status
- Prostate Cancer Recurrent
- DCFPyL
-
Saint-Beauzire, FranceCURIUM PET France
Feb 1, 2021
Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)
Not yet recruiting
- Castration Resistant Prostate Cancer
- Castration Sensitive Prostate Cancer
- Piflufolastat
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 16, 2023
Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)
Recruiting
- Breast Cancer
- +2 more
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Oct 18, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent Trial in Canada, United States (18F-DCFPyL, PET/CT Imaging)
Completed
- Prostate Cancer
- +3 more
- 18F-DCFPyL
- PET/CT Imaging
-
Duarte, California
- +13 more
Jun 10, 2021